XML 26 R22.htm IDEA: XBRL DOCUMENT

Note 9 - Segment Information (Tables)

6 Months Ended

Dec. 31, 2013

Schedule of Segment Reporting Information, by Segment [Table Text Block]

		Sales, Net						Segment
		U.S. Customers		International Customers		Total		Gross Profit		Depreciation		Capital Expenditures
Contract Manufacturing	2013	$	4,973	$	2,819	$	7,792	$	1,208	$	63	$	103
	2012		3,521		2,709		6,230		841		66		-

Branded Proprietary Products	2013		130		322		452		107		1		-
	2012		403		391		794		222		1		-


Other Nutraceutical Businesses	2013		515		29		544		154		2		2
	2012		346		25		371		76		4		-

Total Company	2013		5,618		3,170		8,788		1,469		66		105
	2012		4,270		3,125		7,395		1,139		71		-

		Sales, Net						Segment
		U.S. Customers		International Customers		Total		Gross Profit		Depreciation		Capital Expenditures
Contract Manufacturing	2013	$	10,402	$	5,681	$	16,083	$	2,574	$	129	$	103
	2012		8,397		4,913		13,310		1,937		132		8

Branded Proprietary Products	2013		262		482		744		164		1		-
	2012		990		635		1,625		544		5		-

Other Nutraceutical Businesses	2013		1,059		93		1,152		328		5		2
Businesses	2012		845		95		940		223		7		-

Total Company	2013		11,723		6,256		17,979		3,066		135		105
	2012		10,232		5,643		15,875		2,704		144		8

Reconciliation of Assets from Segment to Consolidated [Table Text Block]

	Total Assets as of
	December 31, 2013		June 30, 2013
Contract Manufacturing	$	7,293	$	8,524

Branded Proprietary Products		2,125		2,186

Other Nutraceutical Businesses		2,348		1,901

Total Company	$	11,766	$	12,611

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details